Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Nutrition Vol. 72 No. 2 October 1960, pp. 169-176
Copyright © 1960 by American Society for Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haley, E. E.
Right arrow Articles by Lambooy, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haley, E. E.
Right arrow Articles by Lambooy, J. P.

The Biological Activity of 6-Chloro-7-Methyl-9-(1'-D-Ribityl)-Isoalloxazine1,2,3,

E. E. Haley and J. P. Lambooy

Department of Physiology, University of Rochester, School of Medicine and Dentistry, Rochester, New York

1. It has been found that 6-chloro-7-methyl-9-(1'-D-ribityl)-isoalloxazine is a reversible antagonist of riboflavin in the nutrition of Lactobacillus casei with an inhibition index of 76.
2. This analog of riboflavin has also been found to be a reversible antagonist in the nutrition of the rat. The growth which is stimulated by low levels of this material is approximately equal to the growth stimulated by one-half the quantity of riboflavin. High levels of the analog are lethal to the animal if adequate amounts of riboflavin are not available.


1 This work was supported in part by grants from the United States Public Health Service. The most recent, Grant no. CY-2940, is from the Cancer Institute.

2 Brief reference to this work was made at the Symposium on the Anitmetabolites, Their Modes of Action and Therapeutic Implications, 10th Annual Meeting, The National Vitamin Foundation, Inc., New York, 1955.

3 This compound has been screened for anti-cancer activity by the Cancer Chemotherapy National Service Center.

Manuscript received 7 May 1960.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]